首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Percutaneous rheolytic thrombectomy for thrombosed autogenous fistulae and prosthetic arteriovenous grafts: outcome after aggressive surveillance and endovascular management.
【24h】

Percutaneous rheolytic thrombectomy for thrombosed autogenous fistulae and prosthetic arteriovenous grafts: outcome after aggressive surveillance and endovascular management.

机译:经血栓性自体瘘管和假体动静脉移植物的经皮流变血栓切除术:积极监测和血管内处理后的结果。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To study the outcome of rheolytic thrombectomy for hemodialysis access occlusion. METHODS: A prospective study was conducted of 187 patients (88 men; median age 63 years, range 21-89) with end-stage renal disease treated with the AngioJet rheolytic thrombectomy catheter followed by angioplasty (+/- stenting) of the culprit lesions in 285 episodes of arteriovenous graft (n = 261) or fistula (n = 24) thrombosis. Clinical success was defined as at least one successful subsequent hemodialysis session. Graft monitoring and surveillance included clinical and hemodialysis parameters, respectively, to detect a failing/failed access. RESULTS: Rheolytic thrombectomy had a technical (immediate) success rate of 98.2% and a clinical success rate of 95.1%. Technical and clinical success for patients presenting within 2 days of the thrombosis was 99.6% and 96.6%, respectively, compared to 91.8% (p = 0.003, odds ratio 20.8) and 87.8% (p = 0.019, odds ratio 4) for later presentation. The number of stenoses that was managed (median, interquartile range) was significantly higher in grafts (4, 3-4) compared to fistulae (2, 2-3; p<0.001) and in accesses that had been treated for dysfunction or thrombosis in the past (4, 3-4) compared to accesses that had not (3, 3-4; p = 0.07). During follow-up, 95 (36.6%) accesses had no further thrombotic events, 23 (9%) accesses became dysfunctional and were treated with endovascular techniques, 137 (52.3%) developed recurrent thrombosis for which rheolytic thrombectomy was attempted, and 30 (11.5%) were abandoned or removed for infection. Functional assisted primary patency at 1, 6, 12, and 18 months was 72.4%, 45.1%, 30.3%, and 22.4%, respectively. Reintervention and venous outflow stenosis were associated with better and worse outcomes, respectively; multivariate analysis identified patient age, central vein stenosis, and stenting as additional independent predictors of improved patency. CONCLUSION: Rheolytic thrombectomy is a highly successful procedure, with acceptable long-term assisted primary patency. Early referral for thrombectomy should be encouraged.
机译:目的:研究流变血栓切除术对血液透析通路闭塞的疗效。方法:一项前瞻性研究针对187例(88名男性,中位年龄63岁,年龄范围21-89)进行了终末期肾脏疾病的患者,采用AngioJet溶血性血栓切除术导管治疗,然后行血管成形术(+/-支架置入术)在285次动静脉移植(n = 261)或瘘管(n = 24)血栓形成中。临床成功被定义为至少一次成功的随后血液透析疗程。移植物监测和监视分别包括临床和血液透析参数,以检测失败/失败的通道。结果:流式血栓切除术的技术(立即)成功率为98.2%,临床成功率为95.1%。在血栓形成后两天内就诊的患者在技术和临床上的成功率分别为99.6%和96.6%,而在以后的研究中,则分别为91.8%(p = 0.003,优势比20.8)和87.8%(p = 0.019,优势比4) 。与瘘管(2、2-3; p <0.001)相比,在移植物中(4、3-4)和经过功能障碍或血栓形成治疗的通道中,被管理的狭窄数量(中位数,四分位间距)明显更高。过去(4,3-4)的访问次数与没有访问(3,3-4; p = 0.07)的访问进行比较。在随访期间,没有再发生血栓事件的有95(36.6%),有功能失调的患者有23(9%),并且接受了血管内技术治疗,其中有137(52.3%)的复发性血栓形成曾尝试进行溶血性血栓切除术,有30( 11.5%)被放弃或移走以进行感染。在1、6、12和18个月时,功能性辅助通畅率分别为72.4%,45.1%,30.3%和22.4%。再干预和静脉流出管狭窄分别与较好和较差的结局相关。多变量分析确定了患者年龄,中心静脉狭窄和支架置入是通畅性改善的其他独立预测因子。结论:流式血栓切除术是一项非常成功的手术,可以接受长期辅助的初级通畅。应鼓励及早转诊血栓切除术。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号